Stay updated on ARO-APOC3 in Dyslipidemia Clinical Trial
Sign up to get notified when there's something new on the ARO-APOC3 in Dyslipidemia Clinical Trial page.

Latest updates to the ARO-APOC3 in Dyslipidemia Clinical Trial page
- CheckyesterdayChange DetectedThe completed ARO-APOC3 study record now includes results reporting, with measures for treatment-emergent adverse events and changes in triglycerides and other lipid markers through Month 24. Eligibility wording and study documents were also updated.SummaryDifference2%

- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now displays the ClinicalTrials.gov record for the completed ARO-APOC3 extension study, including its design, eligibility criteria, locations, outcomes, and study dates, rather than a 403 error response.SummaryDifference63%

- Check21 days agoChange DetectedThe clinical trial study record is no longer displayed; the page instead shows a 403 Forbidden message with a Home link.SummaryDifference16%

- Check29 days agoChange DetectedA banner announces NIH’s transition to using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) across its content.SummaryDifference1%

- Check35 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check42 days agoChange DetectedThe ClinicalTrials.gov footer revision changes from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

Stay in the know with updates to ARO-APOC3 in Dyslipidemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARO-APOC3 in Dyslipidemia Clinical Trial page.